Ear Care in Bulgaria

July 2013 | 22 pages | ID: E122A66504AEN
Euromonitor International Ltd

Abstracts

Ear care registered growth of BGN0.3 million in value terms in 2012. However, value sales showed a quite low level of movement forward due to the limited number of consumer health products available in the market, and the strong competition from Rx products. Most consumers with ear problems avoid purchasing any product before consulting a doctor, and doctors typically recommend Rx products.

Euromonitor International's Ear Care in Bulgaria report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Ear Care market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Ear Care: Value 2007-2012
  Table 2 Sales of Ear Care: % Value Growth 2007-2012
  Table 3 Ear Care Company Shares by Value 2008-2012
  Table 4 Ear Care Brand Shares by Value 2009-2012
  Table 5 Forecast Sales of Ear Care: Value 2012-2017
  Table 6 Forecast Sales of Ear Care: % Value Growth 2012-2017
Sopharma Ad in Consumer Health (bulgaria)
Strategic Direction
Key Facts
Summary 1 Sopharma AD: Key Facts
Summary 2 Sopharma AD: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Sopharma AD: Competitive Position 2012
Executive Summary
Distribution Practices Determine the Main Sales Channels in Consumer Health
Most Consumer Health Categories Are Reaching Maturity
Bulgarians Strongly Rely on Advertising in Consumer Health
Both Internal and External Markets Are Essential for the Growth of Major Domestic Companies
Unlike Other EU Countries, Consumer Health in Bulgaria Is Not Seriously Affected by Recession
Key Trends and Developments
Chemists/pharmacies Is the Most Important Distribution Channel in Consumer Health
Consumer Health Progresses Relatively Well in 2012
Due Legislation Gaps Some Consumer Health Products Are Registered As Foods
Sedentary Lifestyles and Unbalanced Diets Drive Growth in Weight Management
Marketing of OTC Products Is in Need of Stricter Regulation
Market Indicators
  Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
  Table 8 Life Expectancy at Birth 2007-2012
Market Data
  Table 9 Sales of Consumer Health by Category: Value 2007-2012
  Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
  Table 11 Consumer Health Company Shares 2008-2012
  Table 12 Consumer Health Brand Shares 2009-2012
  Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
  Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
  Table 15 Forecast Sales of Consumer Health by Category: Value 2012-2017
  Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Sources
Summary 4 Research Sources